Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Treiner

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
AIDS (London, England)|January 5, 2026
Could a macular telangiectasia type 2-like phenotype characterize retinal JC virus infection?Fanny Varenne, Aurore Siegfried-Vergnon, Sébastien Lhomme, et al.
JAMA Ophthalmology|July 17, 2025
JC Virus-Related RetinopathyFanny Varenne, Aurore Siegfried-Vergnon, Sébastien Lhomme, et al.
Journal of Translational Autoimmunity|July 18, 2024
Urinary soluble CD163 is useful as "liquid biopsy" marker in lupus nephritis at both diagnosis and follow-up to predict impending flaresYves Renaudineau, Dominique Chauveau, Stanislas Faguer, et al.
Plos Biology|March 13, 2009
Stepwise development of MAIT cells in mouse and humanEmmanuel Martin, Emmanuel Treiner, Livine Duban, et al.
International Immunopharmacology|June 5, 2023
Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseasesXavier Boumaza, Margaux Lafaurie, Emmanuel Treiner, et al.
Plos Pathogens|October 17, 2013
MAIT cells detect and efficiently lyse bacterially-infected epithelial cellsLionel Le Bourhis, Mathilde Dusseaux, Armelle Bohineust, et al.
Blood Advances|June 12, 2026
Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathyJean-Roch Le Henaff, Loïc Le Guennec, Pauline Schiro, et al.
Journal of Clinical Immunology|November 22, 2024
2q33 Deletions Underlying Syndromic and Non-syndromic CTLA4 DeficiencyCharlyne Brakta, Anne-Claude Tabet, Mathilde Puel, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
AIDS (London, England)|January 5, 2026
Could a macular telangiectasia type 2-like phenotype characterize retinal JC virus infection?Fanny Varenne, Aurore Siegfried-Vergnon, Sébastien Lhomme, et al.
JAMA Ophthalmology|July 17, 2025
JC Virus-Related RetinopathyFanny Varenne, Aurore Siegfried-Vergnon, Sébastien Lhomme, et al.
Journal of Translational Autoimmunity|July 18, 2024
Urinary soluble CD163 is useful as "liquid biopsy" marker in lupus nephritis at both diagnosis and follow-up to predict impending flaresYves Renaudineau, Dominique Chauveau, Stanislas Faguer, et al.
Plos Biology|March 13, 2009
Stepwise development of MAIT cells in mouse and humanEmmanuel Martin, Emmanuel Treiner, Livine Duban, et al.
International Immunopharmacology|June 5, 2023
Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseasesXavier Boumaza, Margaux Lafaurie, Emmanuel Treiner, et al.
Plos Pathogens|October 17, 2013
MAIT cells detect and efficiently lyse bacterially-infected epithelial cellsLionel Le Bourhis, Mathilde Dusseaux, Armelle Bohineust, et al.
Blood Advances|June 12, 2026
Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathyJean-Roch Le Henaff, Loïc Le Guennec, Pauline Schiro, et al.
Journal of Clinical Immunology|November 22, 2024
2q33 Deletions Underlying Syndromic and Non-syndromic CTLA4 DeficiencyCharlyne Brakta, Anne-Claude Tabet, Mathilde Puel, et al.
Pageof 4